Sun Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM
SUN PHARM has seven hundred and four approved drugs.
There are fifty-nine US patents protecting SUN PHARM drugs. There are twenty tentative approvals on SUN PHARM drugs.
Summary for Sun Pharm
| US Patents: | 59 |
| Tradenames: | 426 |
| Ingredients: | 388 |
| NDAs: | 704 |
| Patent Litigation for Sun Pharm: | See patent lawsuits for Sun Pharm |
| PTAB Cases with Sun Pharm as petitioner: | See PTAB cases with Sun Pharm as petitioner |
Drugs and US Patents for Sun Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 202922-001 | Apr 8, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sun Pharm Inds Ltd | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 078722-001 | May 12, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sun Pharm | INFUGEM | gemcitabine hydrochloride | SOLUTION;INTRAVENOUS | 208313-008 | Jul 16, 2018 | DISCN | Yes | No | 9,241,948 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Sun Pharm Inds | OCTREOTIDE ACETATE | octreotide acetate | INJECTABLE;INJECTION | 077372-003 | Aug 14, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sun Pharma Canada | BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | CREAM;TOPICAL | 073552-001 | Apr 30, 1992 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharm Inds | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 078295-001 | Aug 10, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sun Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Start Trial |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-004 | May 25, 2012 | 9,089,534 | ⤷ Start Trial |
| Sun Pharm Inds Inc | LAC-HYDRIN | ammonium lactate | LOTION;TOPICAL | 019155-001 | Apr 24, 1985 | 4,105,783 | ⤷ Start Trial |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-004 | May 25, 2012 | 8,952,064 | ⤷ Start Trial |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-003 | May 25, 2012 | 7,435,427 | ⤷ Start Trial |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-005 | Aug 15, 2014 | 9,089,534 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 35 mg | ➤ Subscribe | 2015-11-25 |
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-06-19 |
| ➤ Subscribe | Capsules | 30 mg and 40 mg | ➤ Subscribe | 2012-12-31 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
| ➤ Subscribe | Tablets | 125 mg | ➤ Subscribe | 2018-07-23 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-01-07 |
| ➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2016-05-16 |
International Patents for Sun Pharm Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Singapore | 10201709400V | ⤷ Start Trial |
| South Africa | 200800926 | ⤷ Start Trial |
| Canada | 3015626 | ⤷ Start Trial |
| South Korea | 20040023748 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2010102192 | ⤷ Start Trial |
| Australia | 2017261286 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0806968 | SPC/GB07/011 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003 |
| 0152897 | SPC/GB01/012 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115 |
| 1534313 | 300784 | Netherlands | ⤷ Start Trial | PRODUCT NAME: KETOROLAC, OF HET TROMETAMOLZOUT ERVAN, EN FENYLEFRINE, OF HET HYDROCHLORIDEZOUT ERVAN; REGISTRATION NO/DATE: EU/1/15/1018 20150730 |
| 1506211 | C01506211/02 | Switzerland | ⤷ Start Trial | PRODUCT NAME: DAPAGLIFLOZIN + METFORMIN; REGISTRATION NO/DATE: SWISSMEDIC 65377 16.07.2015 |
| 0933372 | PA2008006,C0933372 | Lithuania | ⤷ Start Trial | PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712 |
| 0058146 | 2001C/045 | Belgium | ⤷ Start Trial | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
